Old Web
English
Sign In
Acemap
>
authorDetail
>
Jezaniah‐Kira S. Tena
Jezaniah‐Kira S. Tena
Zoetis
Placebo
Medicine
Dermatology
Dermatologic agents
Janus kinase inhibitor
2
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.
2021
Journal of Veterinary Internal Medicine
Margaret E. Gruen
Jamie A. E. Myers
Jezaniah‐Kira S. Tena
Csilla Becskei
Dawn M. Cleaver
B. Duncan X. Lascelles
Show All
Source
Cite
Save
Citations (0)
A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis
2013
Veterinary Dermatology
Sallie B. Cosgrove
Jody A. Wren
Dawn M. Cleaver
Kelly F. Walsh
Stacey I. Follis
Vickie I. King
Jezaniah‐Kira S. Tena
Michael R. Stegemann
Show All
Source
Cite
Save
Citations (71)
1